Baclofen Tablets 20 mg by Teva a muscle relaxer and an antispastic agent. Baclofen is used to treat muscle symptoms caused by multiple sclerosis, including spasm, pain, and stiffness. Baclofen may also be used for purposes not listed in this medication guide.
Each tablet, for oral administration, contains 20 mg baclofen, USP. In addition, each tablet contains the following inactive ingredients: anhydrous lactose, colloidal silicon dioxide, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose and sodium starch glycolate.
Baclofen tablets are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.
Patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. Baclofen tablets may also be of some value in patients with spinal cord injuries and other spinal cord diseases.
Baclofen tablets are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders.
The efficacy of baclofen in stroke, cerebral palsy, and Parkinson’s disease has not been established and, therefore, it is not recommended for these conditions.
Brand: Teva PharmaceuticalsSize: 100 TabletsStrength: 20 mgNDC: 00172-4097-60UPC: 301724097605
Buy Baclofen Tablets 20 mg by Teva used to treat muscle symptoms caused by multiple sclerosis at Mountainside Medical Equipment.
Buy Baclofen Tablets 20 mg by Teva used to treat muscle symptoms caused by multiple sclerosis at Mountainside Medical Equipment Teva PharmaceuticalsBaclofen Tablets 20 mg by Teva is used for the alleviation of signs and symptoms of muscle spasm resulting from multiple sclerosis, particularly for the relief of pain, clonus, and muscular rigidity. Baclofen tablets are useful for the treatment of multiple sclerosis, especially in the treatment of multiple sclerosis spinal cord injury.
Patients should have reversible spasm resulting from multiple sclerosis spinal cord injury to obtain baclofen tablets.
Baclofen Tablets 20 mg by Teva may also be of some value in patients with spinal cord injuries.
Take Baclofen Tablets 20 mg by Teva by mouth with a full glass of water, with or without food. Swallow the tablet whole with a glass of water. Do not crush, break, or chew the tablet. Baclofen tablets should be swallowed whole, not crushed or chewed.
The dosage of Baclofen Tablets 20 mg by Teva may be adjusted based on signs and symptoms. The signs and symptoms of cerebral palsy should be consistent with spasm resulting from multiple sclerosis spinal cord injury or cerebral palsy.
The treatment of Parkinson's disease should be initiated within a relatively early stage and be symptomatic. Treatment should be symptomatic if the patient is experiencing symptoms such as stiff tics, tremor, or stiffness in the limbs. Treatment should be symptomatic if the patient is experiencing symptoms of stiffness in the legs or torso, such as tremors or jerking of the legs.
The signs and symptoms of stroke may be consistent with spasm resulting from multiple sclerosis spinal cord injury or cerebral palsy.
The treatment of cerebral palsy should be symptomatic.
The use of Baclofen (Lamictal) in the treatment of Parkinson’s disease (PD) and other neurodegenerative diseases has become a growing concern worldwide. However, the availability of oral formulations, particularly in the USA, is still considered as the preferred option for patients who require more effective and safer treatments for PD and other neurodegenerative diseases [
]. Baclofen has a wide range of potential benefits for both the patient and the healthcare system. Baclofen is an effective and well-tolerated drug that has a positive impact on both the patients and the healthcare system [
One of the major advantages of the treatment of PD and other neurodegenerative diseases with Baclofen is its ability to improve the symptoms of PD patients and improve their quality of life [
Additionally, Baclofen has a high rate of tolerability and safety to ensure safe and effective treatment. The Food and Drug Administration (FDA) of the USA has approved this medication for the treatment of PD. Baclofen has been used for over 20 years to treat patients with PD, and its effects have been well-documented in the scientific literature [
The main mechanism of action of Baclofen is a GABA-B receptor agonist-specific inhibition of neurotransmitter receptors, with its effects on dopamine D2 receptors as well as on norepinephrine and dopamine D1 receptors [
Baclofen was developed as a muscle relaxant and anti-nociceptive agent. It is known that GABA is the active ingredient in Baclofen. Therefore, its pharmacokinetics and absorption are believed to be similar to that of other drugs in the drug class [
,
The most common side effects of Baclofen in patients are gastrointestinal upset and nausea. Baclofen is usually well tolerated in patients with PD or other neurodegenerative diseases. The most common adverse effects of Baclofen in patients are gastrointestinal symptoms including nausea and vomiting and drowsiness, headache, dry mouth, and decreased appetite. Baclofen’s high rate of tolerability and safety to ensure safe and effective treatment of PD patients is one of the main advantages of the treatment of PD and other neurodegenerative diseases with Baclofen [
In addition to the above-mentioned side effects, Baclofen has a high rate of absorption, which may cause the patient to experience diarrhea or constipation. Patients who are on higher doses of Baclofen may also experience an increase in the risk of gastrointestinal side effects [
It has been reported that Baclofen may affect the metabolism of various drugs by inhibiting the excretion of excreted Baclofen from the body, which could be due to the fact that Baclofen is extensively metabolized in the body, and there are no pharmacokinetic data on the metabolism of Baclofen in humans. Therefore, the metabolism of Baclofen is not affected by the presence of Baclofen in the body. In the case of Baclofen, there are no pharmacokinetic data on the metabolism of Baclofen in humans. Baclofen is a centrally-acting agent with multiple pharmacological actions. It is a GABA agonist, an inhibitory neurotransmitter, and a central nervous system stimulant [
The mechanism by which Baclofen inhibits the excretion of Baclofen by the CNS is not yet fully understood. The mechanism of Baclofen’s action on the CNS involves the inhibition of the uptake of Baclofen by the CNS and the subsequent release of Baclofen from the body. Baclofen is known to bind to a particular sub-potentiative site in the CNS, which is a receptor site in the brain. Baclofen is known to reduce the excretion of Baclofen from the body by inhibiting the uptake of the drug from the brain [
Baclofen’s main pharmacological effect is the inhibition of the action of norepinephrine and dopamine neurotransmitters [
Baclofen also has a positive effect on the excretion of gamma-aminobutyric acid (GABA) by the CNS [
Baclofen is a muscle relaxer that is primarily used for treating muscle disorders such as spasticity and muscle atrophy. It works by inhibiting the action of serotonin, an enzyme that is normally produced in the central nervous system. This helps alleviate excessive cravings for alcohol and other substances, leading to a decrease in alcohol consumption. Baclofen's effectiveness in treating spasticity is attributed to its ability to alleviate symptoms of the disorder due to its anti-hyperglycemic properties, which means it aids in the reduction of blood sugar levels and helps in reducing muscle atrophy. Additionally, it is widely used off-label for managing muscle spasm and decreasing muscle spasms, particularly in the elderly. This makes it a popular choice among healthcare professionals for individuals with spasticity who wish to alleviate their symptoms.
As of 2024, the baclofen market size projected for baclofen products by product company was valued at USD 2.59 billion and is expected to reach USD 4.52 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 5.4% from 2024 to 2031[1].
North America dominates the baclofen market due to a high volume of sales made in the United States, where Baclofen is primarily used for muscle spasms and muscle spasm. The market is expected to grow at a CAGR of 4.2% from 2024 to 2031, reaching USD 6.4 billion by 2031[2].
The Baclofen market is in its early stages, where it is also in a line-up for region-standard growth. The market is expected to grow at a CAGR of 6.5% from 2024 to 2031, with a growing demand for effective treatments for spasticity and muscle spasm. Countries such as China, Japan, India, and South Korea are likely to see substantial growth due to their strong economy, rising healthcare expenditure, and increasing awareness of spasticity and muscle spasm[1][5].
North America is expected to dominate the baclofen market due to a high volume of sales made in the United States, where Baclofen is primarily used for muscle spasms and muscle spasm. The market is expected to grow at a CAGR of 5.4% from 2024 to 2031, driven by the strong economy, rising healthcare expenditure, and increasing awareness of spasticity and muscle spasm[1].
The baclofen market is expected to reach USD 6.4 billion by 2031, with a Compound Annual Growth Rate (CAGR) of 5.8% from 2024 to 2031[1].
The store will not work correctly in the case when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Type=InboxBox=Disordable Price=Free Discount=Discreet Pack=Discounted Price=High Price=Low Price=Discounted=LowShipping Fee=$0.00Formulation Pack Size=Box=Disordable Price=Free Discount=Discreet Pack=Discounted=Low
Baclofen (Baclofen) is a medication used to treat muscle spasms and stiffness caused by multiple sclerosis, spinal cord injuries, or other neurological disorders. It is often prescribed to people suffering from spasticity or nerve pain due to spinal cord injuries.
is a muscle relaxant, antispastic, and anti-inflammatory agent used to treat muscle spasticity caused by multiple sclerosis, spinal cord injuries, or other neurological disorders. It works by inhibiting the action of certain natural substances that constrain muscles, thereby relieving pain, stiffness, and swelling.
also works by inhibiting the action of certain natural substances that constrain muscles, thereby relieving pain, stiffness, and swelling. Muscle spasms and stiffness caused by multiple sclerosis, spinal cord injuries, or other neurological disorders are often accompanied by muscle pain and spasticity.
The exact mechanism of action of this medication is not fully understood, but it is believed to result from the inhibition of natural muscle relaxation, leading to increased blood flow to muscles. This helps to relieve spasms and stiffness associated with multiple sclerosis, spinal cord injuries, or other neurological disorders.
Baclofen is also effective in reducing the risk of developing kidney damage and bladder cancer.
is a GABA receptor agonist, meaning it increases the excitability of GABA receptors, which relaxes the muscles in the spinal cord and nerves. This reduces muscle spasms, which are the main symptoms of multiple sclerosis, spinal cord injuries, or other neurological disorders. It also helps reduce stiffness caused by multiple sclerosis, spinal cord injuries, or other neurological disorders.
Baclofen is also effective in reducing the risk of developing bladder cancer, heart attack, and kidney damage.
is a muscle relaxant, antispastic, and anti-inflammatory agent used to treat muscle spasms and stiffness caused by multiple sclerosis, spinal cord injuries, or other neurological disorders.
The exact mechanism of action is not fully understood, but it is believed to result from the inhibition of natural muscle relaxation, leading to increased blood flow to muscles.
Stade de France Pharmacy